Angela Cavalieri | Feb. 3, 2014 | Harper Cancer Research Institute
Sharing research across multiple scientific platforms is the foundation on which the Harper Cancer Research Institute was built. This collaborative approach to discovering new treatments to difficult cancers was clearly evident at the recent Pancreatic Cancer Awareness Symposium.
On November 15, more than 50 people gathered—scientific researchers, ND faculty, students, and members of cancer support services organizations—to focus on the challenges of pancreatic ductal adenocarcinoma (PDAC). PDAC is one of the deadliest of all cancers, with a five-year survival rate of 6% and an overall median survival of less than one year. It is the fourth leading cause of cancer-related deaths in the United States. On this day, researchers presented abstracts on several recent breakthroughs in battling pancreatic cancer, and heard a keynote address from Dr. Murray Korc, the Myles Brand Professor of Cancer Research at Indiana University School of Medicine.
The symposium was organized by Reginald Hill, Ph.D., Archibald Assistant Professor of Cancer Biology at Harper. Hill’s intent was to highlight the quality of research being conducted not only by scientists at Harper, but also throughout Indiana.